TrademarkDir
RETUNE
DEAD

Serial Number

88943430

Owner

Marius Pharmaceuticals, LLC

Attorney

Jeffrey J. Ellison

Filing Date

Jun 2, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RETUNE Trademark

Serial Number: 88943430

RETUNE is a trademark filed by Marius Pharmaceuticals, LLC on June 2, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Marius Pharmaceuticals, LLC (18 trademarks)

8601 Six Forks Road, Suite 630
Raleigh, NC 27615

Entity Type: 16

Trademark Details

Filing Date

June 2, 2020

Registration Date

Not Registered

Published for Opposition

October 20, 2020

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 16, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 15, 2024 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 12, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jun 22, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 22, 2023 AITU
SOU EXTENSION 5 FILED
Jun 15, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 17, 2022 EXRA
SOU EXTENSION 4 GRANTED
Dec 15, 2022 EX4G
SOU EXTENSION 4 FILED
Dec 15, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 15, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jun 8, 2022 EX3G
SOU EXTENSION 3 FILED
Jun 8, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2021 EXRA
SOU EXTENSION 2 GRANTED
Dec 14, 2021 EX2G
SOU EXTENSION 2 FILED
Dec 14, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 14, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jun 9, 2021 EX1G
SOU EXTENSION 1 FILED
Jun 9, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 11, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 11, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 11, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 11, 2020 CNEA
ASSIGNED TO EXAMINER
Sep 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2020 NWOS

Related Trademarks

More from this Owner

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY

BASE HEALTHCARE ADEQUATE TESTOSTERONE THERAPY